Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics
- 30 September 1999
- journal article
- clinical trial
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 13 (1) , 15-19
- https://doi.org/10.1016/s0924-8579(99)00096-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Empirical Treatthent of Febrile Neutropenia: Evolution of Current Therapeutic ApproachesClinical Infectious Diseases, 1997
- Empiric Antibiotic Monotherapy with Carbapenems in Febrile Neutropenia: a ReviewJournal of Chemotherapy, 1996
- Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patientsJournal of Antimicrobial Chemotherapy, 1995
- Emergence of Quinolone-Resistant Escherichia coli Bacteremia in Neutropenic Patients with Cancer Who Have Received Prophylactic NorfloxacinClinical Infectious Diseases, 1995
- Editorial Response: Is Resistant Escherichia coli Bacteremia an Inevitable Outcome for Neutropenic Patients Receiving a Fluoroquinolone as Prophylaxis?Clinical Infectious Diseases, 1995
- Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.Journal of Clinical Oncology, 1995
- Beta-Lactam Antibiotic Therapy in Febrile Granulocytopenic PatientsAnnals of Internal Medicine, 1991
- Prevention of Bacterial Infection in Neutropenic Patients with Hematologic MalignanciesAnnals of Internal Medicine, 1991